# Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

> **NCT05636592** · — · ACTIVE_NOT_RECRUITING · sponsor: **The Fourth Affiliated Hospital of Zhejiang University School of Medicine** · enrollment: 250 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** immunotherapy

## Key facts

- **NCT ID:** NCT05636592
- **Lead sponsor:** The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05636592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05636592, "Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05636592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*